Month: May 2026

Celcuity’s Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort

Detailed data for the gedatolisib triplet and doublet regimens will be presented at a late-breaking abstract oral session at the...

E-Scopics Announces New FDA Clearance for Hepatoscope® With Expanded Capabilities in Managing Liver Disease Complications, Advanced Elastography Imaging Features, and Improved Compatibility to Be Presented at DDW 2026

E-Scopics Announces New FDA Clearance for Hepatoscope® With Expanded Capabilities in Managing Liver Disease Complications, Advanced Elastography Imaging Features, and Improved Compatibility to Be Presented at DDW 2026

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies

Also Announces Extension of IR Program VANCOUVER, BC / ACCESS Newswire / May 1, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:...

Queue Ventures Announces Results of its Annual General and Special Meeting in Connection with Previously Announced Plan of Arrangement with Custom Health, Inc.

Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, BC / ACCESS Newswire...

TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health

SAN DIEGO--(BUSINESS WIRE)--Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies...

error: Content is protected !!